Literature DB >> 12071862

Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication.

Bouchaib Bahbouhi1, Nathalie Chazal, Nabil Georges Seidah, Cristina Chiva, Marcelo Kogan, Fernando Albericio, Ernest Giralt, Elmostafa Bahraoui.   

Abstract

The aim of the present study was to evaluate the capacity of synthetic l- and d-peptides encompassing the HIV-1(BRU) gp160 REKR cleavage site to interfere with HIV and simian immuno-deficiency virus (SIV) replication and maturation of the envelope glycoprotein (Env) precursors. To facilitate their penetration into cells, a decanoyl (dec) group was added at the N-terminus. The sequences synthesized included dec5d or dec5l (decREKRV), dec9d or dec9l (decRVVQREKRV) and dec14d or dec14l (TKAKRRVVQREKRV). The peptide dec14d was also prepared with a chloromethane (cmk) group as C-terminus. Because l-peptides exhibit significant cytotoxicity starting at 35 microM, further characterization was conducted mostly with d-peptides, which exhibited no cytotoxicity at concentrations higher than 70 microM. The data show that only dec14d and dec14dcmk could inhibit HIV-1(BRU), HIV-2(ROD) and SIV(mac251) replication and their syncytium-inducing capacities. Whereas peptides dec5d and dec9d were inactive, dec14dcmk was at least twice as active as peptide dec14d. At the molecular level, our data show a direct correlation between anti-viral activity and the ability of the peptides to interfere with maturation of the Env precursors. Furthermore, we show that when tested in vitro the dec14d peptide inhibited PC7 with an inhibition constant K(i)=4.6 microM, whereas the peptide dec14l preferentially inhibited furin with a K(i)=28 microM. The fact that PC7 and furin are the major prohormone convertases reported to be expressed in T4 lymphocytes, the principal cell targets of HIV, suggests that they are involved in the maturation of HIV and SIV Env precursors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071862      PMCID: PMC1222836          DOI: 10.1042/BJ20020052

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation.

Authors:  J W Dubay; S R Dubay; H J Shin; E Hunter
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

2.  Role of beta-turn in proteolytic processing of peptide hormone precursors at dibasic sites.

Authors:  N Brakch; M Rholam; H Boussetta; P Cohen
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

3.  Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides.

Authors:  E Vives; P Charneau; J van Rietschoten; H Rochat; E Bahraoui
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

4.  Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases.

Authors:  F Vollenweider; S Benjannet; E Decroly; D Savaria; C Lazure; G Thomas; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

5.  The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells.

Authors:  S Hallenberger; M Moulard; M Sordel; H D Klenk; W Garten
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Identification of the paired basic convertases implicated in HIV gp160 processing based on in vitro assays and expression in CD4(+) cell lines.

Authors:  E Decroly; S Wouters; C Di Bello; C Lazure; J M Ruysschaert; N G Seidah
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

7.  Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus.

Authors:  M Watanabe; A Hirano; S Stenglein; J Nelson; G Thomas; T C Wong
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM).

Authors:  E Decroly; M Vandenbranden; J M Ruysschaert; J Cogniaux; G S Jacob; S C Howard; G Marshall; A Kompelli; A Basak; F Jean
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

9.  Processing protease for gp160 human immunodeficiency virus type I envelope glycoprotein precursor in human T4+ lymphocytes. Purification and characterization.

Authors:  H Kido; K Kamoshita; A Fukutomi; N Katunuma
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

10.  Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant.

Authors:  E D Anderson; L Thomas; J S Hayflick; G Thomas
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

View more
  3 in total

Review 1.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

Review 2.  HIV envelope: challenges and opportunities for development of entry inhibitors.

Authors:  Michael Caffrey
Journal:  Trends Microbiol       Date:  2011-03-04       Impact factor: 17.079

3.  Predicting proteolytic sites in extracellular proteins: only halfway there.

Authors:  Yossef Kliger; Eyal Gofer; Assaf Wool; Amir Toporik; Avihay Apatoff; Moshe Olshansky
Journal:  Bioinformatics       Date:  2008-03-04       Impact factor: 6.937

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.